9:00 AM-12:00 PM  NIMH Satellite Symposium: CNS Reservoirs

9:00 AM-1:30 PM  Meeting of the Martin Delaney Collaboratories Community Advisory Board

2:00-3:30 PM  NIAID Satellite Symposium : Martin Delaney Collaboratories Research Highlights (Session 1)

3:30-4:00 PM Coffee Break

4:00-05:30 PM Satellite symposia: NIAID

5:30-05:45 CanCURE Overview

5:45-06:00 PM Break

6:00 WELCOME

  • Alain LAFEUILLADE, General Hospital, Toulon, FR

6:05-7:30 PM Opening Lecture
Introduction

Moderators: Karl SALZWEDEL, National Institute of Allergy and Infectious Diseases, Bethesda, US – Alain LAFEUILLADE, General Hospital of Toulon, FR

  • Anthony S. FAUCI, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, WA – US
  • Mike McCUNE, HIV Frontiers, Global Health Innovative Technology Solutions, Bill & Melinda Gates Foundation – US

07:30 Welcome dinner

8:00-10:00 AM – SESSION 1: Basic Science of HIV Latency

Moderators:

  • Una O’DOHERTY,Associate Professor Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, PA – US

1st Lecturer :

Cellular Mechanisms that Establish and Maintain HIV Latency

  • Andrew HENDERSON, Professor of Medicine, Assistant Dean Graduate Medical Sciences
    Department of Medicine and Microbiology, Section of Infectious Diseases Boston University School of Medicine, Boston, MA- US

10 :00-10 :30 AM Coffee Break

10:30-12:30 PM – SESSION 2: In Vitro and Animal Model Studies of HIV Persistence

Moderators :

  • Ann CHAHROUDI, Associate Professor Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, PA – US
  • Afam OKOYE, Research Associate Professor Vaccine & Gene Therapy Institute, and Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton – US

1st Lecturer :

  • J. Victor GARCIA MARTINEZ, Professor of Medicine, Center for AIDS Research, Division of Infectious Diseases, Chapel Hill – US

 

Understanding the establishment and persistence of the rebound competent reservoir using barcoded viruses

  • Brandon F. KEELE, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory, Frederick – US

12:30-2:00 PM Lunch

2:00-3:30 PM – SESSION 3: Virology of HIV persistence

Moderators :

  • Katherine BAR, Associate professor of medicine, Perelman School of Medicine, University of Pennsylvania, Pensylvania
  • Zabrina BRUMME, Director, Laboratory Program, BC Centre for Excellence in HIV/AIDS, Saint Paul Hospital, Vancouver – CAN

1st Lecturer :
CD4-MBL-CAR/CXCR5 T cell immunotherapy shows promise at reducing SIV replication post-ART release

  • Pamela SKINNER, Professor Department of Veterinary and Biomedical Sciences Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program, University of Minnesota, MN – US

3.30 -4.00 PM Coffee Break

4:00 -7.00 PM – POSTER SESSION // POSTER VIEWING with wine and cheese tasting

7 :00 PM Free dinner

8:00-10:00 AM – SESSION 4: Immunology of HIV persistence

Moderators:

  • Lydie TRAUTMANN,Chief, Cellular Immunology Section I HJFIn support of the U.S. Military HIV Research Program (MHRP), Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD – US
  • Brad JONES,Assistant Professor, Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Columbia, WA – US

1st Lecturer :

  • Bruce WALKER, Founding Director of the Ragon Institute of MGH, MIT and Harvard and the Director of the Harvard University Center for AIDS Research, Cabridge, MA – US

HIV persistence during ART: Keeping memory, keeping HIV

  • Nicolas CHOMONT, Associate Professor in the Department of Microbiology and Immunology at the Université de Montréal – CHUM Research Center, Montreal – CAN

10 :00-10 :30 AM Coffee Break

10:30-12:30 PM – SESSION 5: Drug discovery and development

Moderators:

  • Bonnie HOWELL, Executive Director, Infectious Disease and Vaccines Merck, West Point, Pennsylvania, PE – US
  • Guenter KRAUS, Infectious Diseases – Research & Early Development Liaison Officer Janssen Infectious Diseases, Miami, FL – US

1st Lecturer :

Discovery and development of novel latency reversing agents

  • Richard DUNHAM, Scientific Leader and Fellow at ViiV Healthcare; Adj Asst Professor at UNC-CH Région de Raleigh-Durham, NC – US
  • Romas GELEZIUNAS, Executive Director, Biology, Foster City, CA – US

12:30-2:00 PM Lunch

2:00-3:30 PM – SESSION 6: New Therapeutic Approaches I

Moderators:

  • Ya-Chi HO, Assistant Professor of Microbial Pathogenesis and Medicine; Investigator, HIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG) New Haven, CT – US
  • Kevin MORRIS, Professor, Center for Gene Therapy, Hematologic Malignancies and Stem Cell Institute, City of Hope, Duarte, CA – US

1st Lecturer :

A viable pathway to HIV-1 remission

  • Michael FARZAN, Professor an d co-chair of the Department of Immunology and Microbiology on the Florida campus of The Scripps Research Institute, FL – US

3.30 – 4.00 PM Coffee Break

4:00 -7.00 PM – POSTER SESSION // POSTER VIEWING with wine and cheese tasting

7:00 PM Free evening

8:00-10:00 AM – SESSION 7: Human Studies

Moderators:

  • Jonathan KARN, Professor and Chair, Department of Molecular Biology and Microbiology, School of Medicine, Director, Case Center for AIDS Research, Cleveland/Akron, OH – US

1st Lecturer :

Main challenges of human studies in the HIV eradication field

  • Beatriz MOTHE PUJADAS, MD, PhD. Associate Investigator. HIV Unit & IrsiCaixa AIDS Research Institute. Hospital Germans Trias i Pujol. UVic-UC, Barcelona – ES
  • Timothy HENRICH, Associate Professor of Medicine at University of California, San Francisco, CA – US

10:00-10:30 AM Coffee Break

10:30-12:30 PM – SESSION 8: New therapeutic approaches II

Moderators:

  • Susanna VALENTE, Associate Professor Department of Immunology and Microbiology130 Scripps Way, 3C1, Jupiter, FL – US

1st Lecturer :

Genome editing against HIV

  • Paula CANNON, Professor of Molecular Microbiology & Immunology; Associate Director of Cross School Programs for the MESH Academy Molecular Microbiology and Immunology, Los Angeles, CA – USA

12:30 PM Closing ceremony